Thomas W. Beetham - Net Worth and Insider Trading
Thomas W. Beetham Net Worth
The estimated net worth of Thomas W. Beetham is at least $6 Million dollars as of 2024-05-14. Thomas W. Beetham is the EVP & Chief Legal Officer of Kiniksa Pharmaceuticals Ltd and owns about 297,523 shares of Kiniksa Pharmaceuticals Ltd (KNSA) stock worth over $6 Million. Thomas W. Beetham is also the See Remarks of Magenta Therapeutics Inc and owns about 13,897 shares of Magenta Therapeutics Inc (MGTA) stock worth over $9,722. Details can be seen in Thomas W. Beetham's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas W. Beetham has not made any transactions after 2021-09-16 and currently still holds the listed stock(s).
Transaction Summary of Thomas W. Beetham
Thomas W. Beetham Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas W. Beetham owns 3 companies in total, including Kiniksa Pharmaceuticals Ltd (KNSA) , Magenta Therapeutics Inc (MGTA) , and Viridian Therapeutics Inc (VRDN) .
Click here to see the complete history of Thomas W. Beetham’s form 4 insider trades.
Insider Ownership Summary of Thomas W. Beetham
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals Ltd | 2021-02-03 | 10 percent owner & Chief Legal Officer |
| MGTA | Magenta Therapeutics Inc | 2021-09-16 | See Remarks |
| VRDN | Viridian Therapeutics Inc | 2023-10-30 | Chief Operating Officer |
Thomas W. Beetham Latest Holdings Summary
Thomas W. Beetham currently owns a total of 2 stocks. Among these stocks, Thomas W. Beetham owns 297,523 shares of Kiniksa Pharmaceuticals Ltd (KNSA) as of February 3, 2021, with a value of $6 Million and a weighting of 99.83%. Thomas W. Beetham also owns 13,897 shares of Magenta Therapeutics Inc (MGTA) as of September 16, 2021, with a value of $9,722 and a weighting of 0.17%.
Latest Holdings of Thomas W. Beetham
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals Ltd | 2021-02-03 | 297,523 | 19.42 | 5,777,897 |
| MGTA | Magenta Therapeutics Inc | 2021-09-16 | 13,897 | 0.70 | 9,722 |
Holding Weightings of Thomas W. Beetham
Thomas W. Beetham Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas W. Beetham has made a total of 5 transactions in Kiniksa Pharmaceuticals Ltd (KNSA) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Kiniksa Pharmaceuticals Ltd is the sale of 2,477 shares on February 3, 2021, which brought Thomas W. Beetham around $54,717.
According to the SEC Form 4 filings, Thomas W. Beetham has made a total of 1 transactions in Magenta Therapeutics Inc (MGTA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Magenta Therapeutics Inc is the sale of 6,103 shares on September 16, 2021, which brought Thomas W. Beetham around $41,073.
Insider Trading History of Thomas W. Beetham
- 1
Thomas W. Beetham Trading Performance
Thomas W. Beetham Ownership Network
Thomas W. Beetham Owned Company Details
What does Kiniksa Pharmaceuticals Ltd do?
Who are the key executives at Kiniksa Pharmaceuticals Ltd?
Thomas W. Beetham is the 10 percent owner & Chief Legal Officer of Kiniksa Pharmaceuticals Ltd. Other key executives at Kiniksa Pharmaceuticals Ltd include director & 10 percent owner & Chairman & CEO Sanj K Patel , Chief Accounting Officer Michael R Megna , and Chief Medical Officer John Paolini .
Kiniksa Pharmaceuticals Ltd (KNSA) Insider Trades Summary
Over the past 18 months, Thomas W. Beetham made no insider transaction in Kiniksa Pharmaceuticals Ltd (KNSA). Other recent insider transactions involving Kiniksa Pharmaceuticals Ltd (KNSA) include a net sale of 68,156 shares made by John Paolini , a net sale of 83,336 shares made by Sanj K Patel , and a net sale of 24,101 shares made by Michael R Megna .
In summary, during the past 3 months, insiders sold 108,277 shares of Kiniksa Pharmaceuticals Ltd (KNSA) in total and bought 0 shares, with a net sale of 108,277 shares. During the past 18 months, 197,552 shares of Kiniksa Pharmaceuticals Ltd (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 197,552 shares.
Kiniksa Pharmaceuticals Ltd (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kiniksa Pharmaceuticals Ltd Insider Transactions
Thomas W. Beetham Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas W. Beetham. You might contact Thomas W. Beetham via mailing address: C/o Kiniksa Pharmaceuticals, Ltd., Clarendon House, 2 Church Street, Hamilton D0 Hm11.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
